Literature DB >> 29391981

Evaluation of bcl-2, bax and c-erbB-2 Levels in Chronic Otitis Patients with or without Cholesteatoma.

Özgür Işık1, Turgut Karlıdağ1, Bengü Çobanoğlu Şimşek2, Erol Keleş1, İrfan Kaygusuz1, Şinasi Yalçın1, İsrafil Orhan3, Emrah Sapmaz4.   

Abstract

OBJECTIVE: The aim of this study was to evaluate bcl-2, bax, and c-erbB-2 expressions in primary and secondary acquired cholesteatoma and to indicate the role of apoptosis and accompanying increased cellular proliferation in the pathogenesis of cholesteatoma.
METHODS: Samples obtained from the skin of the external ear canal (EEC) of patients operated for chronic otitis media (COM) without cholesteatoma constituted Group 1; samples from the EEC skin of patients in Group 3 operated for COM with cholesteatoma and from the EEC skin of patients in Group 4 constituted Group 2; samples obtained from the cholesteatoma matrix of patients operated for COM with primary acquired cholesteatoma constituted Group 3; and samples obtained from the cholesteatoma matrix of patients operated for COM with secondary acquired cholesteatoma constituted Group 4. The assessment of the positive cell ratio was based on the presence of the following findings and was semiquantitatively classified into four groups: 0, no staining; + cell staining (weak positive staining: 1%-33%); ++ cell staining (moderately positive staining: 34%-66%); and +++ cell staining (strong positive staining: 67%-100%).
RESULTS: Comparison of the staining scores of bcl-2, bax, and c-erbB-2 revealed a statistically insignificant difference in the staining of samples obtained from the EEC skin (p>0.05). Decreased bcl-2 expression and increased bax and c-erbB-2 expressions were determined in primary and secondary acquired cholesteatoma epithelium compared with the EEC skin of patients operated for COM with or without cholesteatoma, and the differences were found to be statistically significant (p<0.05).
CONCLUSION: In acquired cholesteatoma epithelium, the finding of decreased bcl-2 expression as well as increased bax and c-erbB-2 expressions compared with the EEC skin is an indicator of the increase in both cellular proliferation and apoptosis.

Entities:  

Keywords:  Cholesteatoma; apoptosis; bax; bcl-2; c-erbB-2; cell proliferation

Year:  2015        PMID: 29391981      PMCID: PMC5783001          DOI: 10.5152/tao.2015.1159

Source DB:  PubMed          Journal:  Turk Arch Otorhinolaryngol        ISSN: 2667-7466


  25 in total

Review 1.  Complex interplay among apoptosis factors: RB, p53, E2F, TGF-beta, cell cycle inhibitors and the bcl2 gene family.

Authors:  V Chiarugi; L Magnelli; M Cinelli
Journal:  Pharmacol Res       Date:  1997-04       Impact factor: 7.658

2.  Apoptosis in meatal skin, cholesteatoma and squamous cell carcinoma of the ear.

Authors:  S Ergün; B Carlsöö; X Zheng
Journal:  Clin Otolaryngol Allied Sci       Date:  1999-08

3.  Hyperproliferation-associated keratin expression in human middle ear cholesteatoma.

Authors:  J Bujía; V Schilling; A Holly; M Stammberger; E Kastenbauer
Journal:  Acta Otolaryngol       Date:  1993-05       Impact factor: 1.494

4.  Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis.

Authors:  Margriet A Huisman; Emile De Heer; Jan J Grote
Journal:  Acta Otolaryngol       Date:  2003-04       Impact factor: 1.494

5.  Increased expression of p63 and survivin in cholesteatomas.

Authors:  H R Park; S K Min; K Min; S Y Jun; J Seo; H J Kim
Journal:  Acta Otolaryngol       Date:  2009-03       Impact factor: 1.494

6.  Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance.

Authors:  H Kojima; K Endo; H Moriyama; Y Tanaka; E S Alnemri; C A Slapak; B Teicher; D Kufe; R Datta
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

7.  Overexpression of Bcl-XL by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation.

Authors:  R Datta; Y Manome; N Taneja; L H Boise; R Weichselbaum; C B Thompson; C A Slapak; D Kufe
Journal:  Cell Growth Differ       Date:  1995-04

8.  Animal model for cholesteatoma induced in the gerbil: will the profiles of differentiation/growth-regulatory markers be similar to the clinical situation?

Authors:  Georges Choufani; Nicolas Roper; Carine Delbrouck; Sergio Hassid; Hans-Joachim Gabius
Journal:  Laryngoscope       Date:  2007-04       Impact factor: 3.325

9.  Antigen expression of epithelial markers, collagen IV and Ki67 in middle ear cholesteatoma. An immunohistochemical Study.

Authors:  S Ergün; X Zheng; B Carlsöö
Journal:  Acta Otolaryngol       Date:  1994-05       Impact factor: 1.494

10.  The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins.

Authors:  I Marzo; C Brenner; N Zamzami; S A Susin; G Beutner; D Brdiczka; R Rémy; Z H Xie; J C Reed; G Kroemer
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.